Cite
The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials.
MLA
Maiorino, Maria Ida, et al. “The Good Companions: Insulin and Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetes. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Diabetes Research & Clinical Practice, vol. 154, Aug. 2019, pp. 101–15. EBSCOhost, https://doi.org/10.1016/j.diabres.2019.06.009.
APA
Maiorino, M. I., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D., & Esposito, K. (2019). The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials. Diabetes Research & Clinical Practice, 154, 101–115. https://doi.org/10.1016/j.diabres.2019.06.009
Chicago
Maiorino, Maria Ida, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, and Katherine Esposito. 2019. “The Good Companions: Insulin and Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetes. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Diabetes Research & Clinical Practice 154 (August): 101–15. doi:10.1016/j.diabres.2019.06.009.